Compare Roivant Sciences Ltd. Common Shares (ROIV) vs Viasat (VSAT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Roivant Sciences Ltd. Common Shares vs Viasat — how do they compare? Roivant Sciences Ltd. Common Shares trades at $34.21 (market cap $25.09B), while Viasat trades at $69 (market cap $9.76B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 2.6× Viasat's market cap, and Roivant Sciences Ltd. Common Shares is more actively traded (5,738,571 versus 1,739,997). Which is the better fit depends on your goals — on Pluang, investors hold Roivant Sciences Ltd. Common Shares for 0 Days and Viasat for 10 Days on average.
| ROIV | VSAT | |
|---|---|---|
Market Cap | $25.09B | $9.76B |
Volume | 5,738,571 | 1,739,997 |
Sector | Health | Technology |
52-Week High | $41.81 | $89.81 |
52-Week Low | $16.04 | $30.35 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $21.36B | $14.95B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →About Viasat
Viasat provides satellite communications and connectivity services for aviation, maritime, government, enterprise, and consumer markets. Its network combines satellite and ground infrastructure to deliver connectivity in remote and mobile environments.
Read more on VSAT →
